These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 24043310)

  • 1. SIRT4 represses peroxisome proliferator-activated receptor α activity to suppress hepatic fat oxidation.
    Laurent G; de Boer VC; Finley LW; Sweeney M; Lu H; Schug TT; Cen Y; Jeong SM; Li X; Sauve AA; Haigis MC
    Mol Cell Biol; 2013 Nov; 33(22):4552-61. PubMed ID: 24043310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SIRT4 regulates fatty acid oxidation and mitochondrial gene expression in liver and muscle cells.
    Nasrin N; Wu X; Fortier E; Feng Y; Bare' OC; Chen S; Ren X; Wu Z; Streeper RS; Bordone L
    J Biol Chem; 2010 Oct; 285(42):31995-2002. PubMed ID: 20685656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CDKN2A/p16INK4a suppresses hepatic fatty acid oxidation through the AMPKα2-SIRT1-PPARα signaling pathway.
    Deleye Y; Cotte AK; Hannou SA; Hennuyer N; Bernard L; Derudas B; Caron S; Legry V; Vallez E; Dorchies E; Martin N; Lancel S; Annicotte JS; Bantubungi K; Pourtier A; Raverdy V; Pattou F; Lefebvre P; Abbadie C; Staels B; Haas JT; Paumelle R
    J Biol Chem; 2020 Dec; 295(50):17310-17322. PubMed ID: 33037071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation.
    Purushotham A; Schug TT; Xu Q; Surapureddi S; Guo X; Li X
    Cell Metab; 2009 Apr; 9(4):327-38. PubMed ID: 19356714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SIRT4 coordinates the balance between lipid synthesis and catabolism by repressing malonyl CoA decarboxylase.
    Laurent G; German NJ; Saha AK; de Boer VC; Davies M; Koves TR; Dephoure N; Fischer F; Boanca G; Vaitheesvaran B; Lovitch SB; Sharpe AH; Kurland IJ; Steegborn C; Gygi SP; Muoio DM; Ruderman NB; Haigis MC
    Mol Cell; 2013 Jun; 50(5):686-98. PubMed ID: 23746352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sirt4 is a mitochondrial regulator of metabolism and lifespan in
    Wood JG; Schwer B; Wickremesinghe PC; Hartnett DA; Burhenn L; Garcia M; Li M; Verdin E; Helfand SL
    Proc Natl Acad Sci U S A; 2018 Feb; 115(7):1564-1569. PubMed ID: 29378963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of SIRT4 promotes the self-renewal of Breast Cancer Stem Cells.
    Du L; Liu X; Ren Y; Li J; Li P; Jiao Q; Meng P; Wang F; Wang Y; Wang YS; Wang C
    Theranostics; 2020; 10(21):9458-9476. PubMed ID: 32863939
    [No Abstract]   [Full Text] [Related]  

  • 8. PARP1-mediated PPARα poly(ADP-ribosyl)ation suppresses fatty acid oxidation in non-alcoholic fatty liver disease.
    Huang K; Du M; Tan X; Yang L; Li X; Jiang Y; Wang C; Zhang F; Zhu F; Cheng M; Yang Q; Yu L; Wang L; Huang D; Huang K
    J Hepatol; 2017 May; 66(5):962-977. PubMed ID: 27979751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SIRT4 regulates ATP homeostasis and mediates a retrograde signaling via AMPK.
    Ho L; Titus AS; Banerjee KK; George S; Lin W; Deota S; Saha AK; Nakamura K; Gut P; Verdin E; Kolthur-Seetharam U
    Aging (Albany NY); 2013 Nov; 5(11):835-49. PubMed ID: 24296486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PPARα and Sirt1 mediate erythropoietin action in increasing metabolic activity and browning of white adipocytes to protect against obesity and metabolic disorders.
    Wang L; Teng R; Di L; Rogers H; Wu H; Kopp JB; Noguchi CT
    Diabetes; 2013 Dec; 62(12):4122-31. PubMed ID: 23990359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic sirtuin 1 is dispensable for fibrate-induced peroxisome proliferator-activated receptor-α function in vivo.
    Bonzo JA; Brocker C; Jiang C; Wang RH; Deng CX; Gonzalez FJ
    Am J Physiol Endocrinol Metab; 2014 Apr; 306(7):E824-37. PubMed ID: 24496310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SIRT5 is under the control of PGC-1α and AMPK and is involved in regulation of mitochondrial energy metabolism.
    Buler M; Aatsinki SM; Izzi V; Uusimaa J; Hakkola J
    FASEB J; 2014 Jul; 28(7):3225-37. PubMed ID: 24687991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acetylation of Mitochondrial Trifunctional Protein α-Subunit Enhances Its Stability To Promote Fatty Acid Oxidation and Is Decreased in Nonalcoholic Fatty Liver Disease.
    Guo L; Zhou SR; Wei XB; Liu Y; Chang XX; Liu Y; Ge X; Dou X; Huang HY; Qian SW; Li X; Lei QY; Gao X; Tang QQ
    Mol Cell Biol; 2016 Oct; 36(20):2553-67. PubMed ID: 27457618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PPARα (Peroxisome Proliferator-activated Receptor α) Activation Reduces Hepatic CEACAM1 Protein Expression to Regulate Fatty Acid Oxidation during Fasting-refeeding Transition.
    Ramakrishnan SK; Khuder SS; Al-Share QY; Russo L; Abdallah SL; Patel PR; Heinrich G; Muturi HT; Mopidevi BR; Oyarce AM; Shah YM; Sanchez ER; Najjar SM
    J Biol Chem; 2016 Apr; 291(15):8121-9. PubMed ID: 26846848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxygen flux analysis to understand the biological function of sirtuins.
    Wang D; Green MF; McDonnell E; Hirschey MD
    Methods Mol Biol; 2013; 1077():241-58. PubMed ID: 24014411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential regulation of peroxisome proliferator-activated receptor (PPAR)-alpha1 and truncated PPARalpha2 as an adaptive response to fasting in the control of hepatic peroxisomal fatty acid beta-oxidation in the hibernating mammal.
    El Kebbaj Z; Andreoletti P; Mountassif D; Kabine M; Schohn H; Dauça M; Latruffe N; El Kebbaj MS; Cherkaoui-Malki M
    Endocrinology; 2009 Mar; 150(3):1192-201. PubMed ID: 18948393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of diet-induced hepatic steatosis by peripheral CB1 receptor blockade in mice is p53/miRNA-22/SIRT1/PPARα dependent.
    Azar S; Udi S; Drori A; Hadar R; Nemirovski A; Vemuri KV; Miller M; Sherill-Rofe D; Arad Y; Gur-Wahnon D; Li X; Makriyannis A; Ben-Zvi D; Tabach Y; Ben-Dov IZ; Tam J
    Mol Metab; 2020 Dec; 42():101087. PubMed ID: 32987186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic ATF6 Increases Fatty Acid Oxidation to Attenuate Hepatic Steatosis in Mice Through Peroxisome Proliferator-Activated Receptor α.
    Chen X; Zhang F; Gong Q; Cui A; Zhuo S; Hu Z; Han Y; Gao J; Sun Y; Liu Z; Yang Z; Le Y; Gao X; Dong LQ; Gao X; Li Y
    Diabetes; 2016 Jul; 65(7):1904-15. PubMed ID: 27207533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Mitochondrial Sirtuins (SIRT3, SIRT4 and SIRT5) in Renal Cell Metabolism: Implication for Kidney Diseases.
    Juszczak F; Arnould T; Declèves AE
    Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 39000044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipin 1 is an inducible amplifier of the hepatic PGC-1alpha/PPARalpha regulatory pathway.
    Finck BN; Gropler MC; Chen Z; Leone TC; Croce MA; Harris TE; Lawrence JC; Kelly DP
    Cell Metab; 2006 Sep; 4(3):199-210. PubMed ID: 16950137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.